Name | VERU-111 |
---|
Description | VERU-111 (ABI-231) is a potent and orally bioavailable α and β tubulin inhibitor, which displays strong antiproliferative activity, with an average IC50 of 5.2 nM against panels of melanoma and prostate cancer cell lines. VERU-111 (ABI-231) suppresses tumor growth and metastatic phenotypes of cervical cancer cells via targeting HPV E6 and E7, and has potential for the treatment of prostate cancer[1][2][3]. |
---|---|
Related Catalog | |
Target |
tubulin[1] |
References |
Molecular Formula | C21H19N3O4 |
---|---|
Molecular Weight | 377.39 |